Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
3
60%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
Enrolling by invitation1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 33 (75.0%)

Trials by Status

enrolling_by_invitation120%
completed360%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
enrolling_by_invitation

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

NCT07023965
completedphase_3

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

NCT04274049
completedphase_3

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

NCT04275323
unknownphase_3

Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients

NCT05968118
completedphase_2

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

NCT01548378

Clinical Trials (5)

Showing 5 of 5 trials
NCT07023965

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Enrolling By Invitation
NCT04274049Phase 3

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

Completed
NCT04275323Phase 3

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

Completed
NCT05968118Phase 3

Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients

Unknown
NCT01548378Phase 2

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5